Showing results (2991-3000 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 23, 2022
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCCEliza Guti, Zsolt Regdon, Isotta Sturniolo, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2018
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristicsSotirios P Fortis, Christoforos K Vaxevanis, Louisa G Mahaira, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2018
Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinomaWei Wang, Hanna M Ollila, Alice S Whittemore, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysisH G Drexler, M Menon, G Gaedicke, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancerK J McCormick, W R Panje
Cancer Immunology, Immunotherapy : CII|September 28, 2021
Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotideJen-Chih Tseng, Jing-Xing Yang, Yi-Ling Liu, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Adriamycin induced resistance of sensitive K 562 cells to natural killer lymphocyte attackH Benoist, C Madoulet, J C Jardillier, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Activation of natural resistance against lung metastasis of an adenocarcinoma in T-cell depressed spontaneously hypertensive rats by infection with Listeria monocytogenesY Koga, J Hamada, N Takeichi, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes. Survival benefit of adjuvant post-surgical treatments and comparison with experimental metastases modelM Rodolfo, C Salvi, C Bassi, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2012
FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanomaLotte Engell-Noerregaard, Helle W Hendel, Helle H Johannesen, et al.
Pageof 652